两种前列腺影像报告和数据系统版本诊断性能的比较:一项系统评价
该系统评价纳入14项头对头比较研究共1682例患者,比较PI-RADS v1与v2检测前列腺癌的诊断性能。汇总敏感度分别为85.37%与87.79%,特异度分别为77.26%与76.73%,两者诊断准确率无实质差异(敏感度P=0.57,特异度P=0.96)。
要点
- PI-RADS v1与v2检测前列腺癌的汇总敏感度和特异度均无实质差异。
- 移行区PI-RADS v2敏感度似乎高于v1(90.1% vs 80.59%),但差异未达统计学显著(P=0.17)。
- PI-RADS v2敏感度略高,但以特异度轻微下降为代价。
核心结论
- PI-RADS v2敏感度略高,但特异度轻微下降,总体上PI-RADS v1与v2诊断准确率相当。
研究设计与样本
- 系统评价,检索MEDLINE、EMBASE、Cochrane Library、Google Scholar、CNKI及万方数据库,自建库至2018年9月31日,纳入14项PI-RADS v1与v2头对头比较研究,共1682例患者,采用QUADAS-2工具评价文献质量。
诊断标准与关键数值
- PI-RADS v1汇总敏感度85.37%(95%CI 79.29%-89.89%),汇总特异度77.26%(95%CI 57.29%-89.58%);PI-RADS v2汇总敏感度87.79%(95%CI 79.84%-92.88%),汇总特异度76.73%(95%CI 58.69%-88.44%);敏感度差异P=0.57,特异度差异P=0.96;移行区PI-RADS v1敏感度80.59% vs PI-RADS v2 90.1%(P=0.17)。
局限性
- 移行区PI-RADS v2敏感度高于v1(90.1% vs 80.59%),但差异未达统计学显著(P=0.17)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the diagnostic performance between Prostate Imaging Reporting and Data System version 1(PI-RADS v1) and PI-RADS v2 for detection of prostate cancer (PCa).
METHODS: A systematic literature search was performed from inception to September 31, 2018, in following databases MEDLINE, EMBASE, Cochrane Library, Google Scholar, in addition to Chinese National Knowledge Infrastructure (CNKI) and Wanfang Data database. Sensitivity and specificity of individual studies along with summary estimates were calculated and presented in forest plots. Multiple subgroup analyses and meta-regression were performed to investigate the heterogeneity. Quality of included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool.
RESULTS: 14 studies involving head to head comparison between PI-RADS v1 and v2 were included, with a total of 1682 patients. The pooled sensitivity for PI-RADS v1 and PI-RADS v2 were 85.37% (95% CI 79.29%-89.89%) and 87.79% (95% CI 79.84%-92.88%), with pooled specificity of 77.26% (95% CI 57.29%-89.58%) and 76.73% (95% CI 58.69%-88.44%), respectively. There was no substantial difference in diagnostic accuracy between PI-RADS v1 and PI-RADS v2 (P = 0.57 for sensitivity and P = 0.96 for specificity). Multiple subgroup analyses and meta-regression suggested these two scoring systems had comparable diagnostic performance on magnetic field strength, zonal anatomy, and outcome assessment. For the transitional zone, it seemed that PI-RADS v2 had higher sensitivity than PI-RADS v1 (90.1% vs. 80.59%), but the difference was not substantial (P = 0.17).
CONCLUSION: PI-RADS v2 has slightly higher sensitivity but at the expense of minor decreased specificity. Thus, on the whole PI-RADS v1 and PI-RADS v2 have comparable diagnostic accuracy.
引用
- Li W, Xin C, Zhang L, et al. Comparison of diagnostic performance between two prostate imaging reporting and data system versions: A systematic review. Eur J Radiol. 2019. PMID: 31005160. doi:10.1016/j.ejrad.2019.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。